Roquefort Therapeutics plc (LON:ROQ)
London · Delayed Price · Currency is GBP · Price in GBX 1.650
-0.125 (-7.55%)
Aug 18, 2025, 4:35 PM BST
Roquefort Therapeutics Market Cap
Roquefort Therapeutics has a market cap or net worth of 2.60 million as of August 18, 2025. Its market cap has decreased by -51.53% in one year.
Market Cap
2.60M
Enterprise Value
2.66M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.65
Market Cap Chart
Since March 22, 2021, Roquefort Therapeutics's market cap has increased from 2.19M to 2.60M, an increase of 18.78%. That is a compound annual growth rate of 3.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 2.60M | -52.74% |
| Dec 31, 2024 | 5.50M | -41.29% |
| Dec 29, 2023 | 9.36M | 9.43% |
| Dec 30, 2022 | 8.56M | 13.33% |
| Dec 31, 2021 | 7.55M | 245.20% |
| Mar 22, 2021 | 2.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 179.76B |
| GSK plc | 57.11B |
| Haleon | 31.97B |
| Smith & Nephew | 11.74B |
| ConvaTec Group | 4.66B |
| Hikma Pharmaceuticals | 3.97B |
| HUTCHMED (China) | 2.09B |
| Oxford Nanopore Technologies | 2.02B |